Abstracts

Genital and Extragenital Sexually Transmitted Infections Among Reproductive Age Women in Southern US

Background: Sexually transmitted infections (STI) are highly prevalent among women of reproductive age (WRA) and increase the risk of HIV acquisition and transmission. However, the burden of genital and extragenital STIs is understudied among WRA in the U.S. Estimates of disease are urgently needed, including among women with and without HIV, to inform sex-specific screening…

Routine Emergency Department Screening Increases Syphilis Diagnosis Among Pregnant Patients

Background: Considering the recent surge in congenital syphilis, novel means of reaching vulnerable populations for testing and treatment are needed. The CDC recently suggested screening outside traditional prenatal care settings might be an effective strategy. As the primary source of healthcare for many communities with limited access to care, visits to the emergency department (ED)…

Prevalence of Syphilis and HIV/Syphilis Coinfection in an Inner-City Emergency Department

Background: Syphilis has had a resurgence in the United States. Untreated syphilis infections have detrimental health effects, and improved screening procedures are needed to control the epidemic. We performed a retrospective, deidentified cross-sectional analysis of individuals attending the Johns Hopkins Emergency Department (JHHED) to determine the prevalence of syphilis and HIV, as well as the…

Doxycycline Postexposure Prophylaxis to Prevent Trichomonas vaginalis Among Cisgender Women

Background: Trichomonas vaginalis, the most prevalent curable sexually transmitted infection (STI), disproportionately affects cisgender women, leading to reproductive complications and increased HIV acquisition risk. In-vitro studies suggest doxycycline as a potential treatment; however, no study has explored the ability of doxycycline to prevent T. vaginalis infection. Methods: We conducted an open-label randomized trial among 449…

Safety and Pharmacokinetics of Ultra-Long-Acting Dolutegravir In-Situ Forming Implant

Background: Long-acting injectables (LAIs) for HIV PrEP can increase user acceptability, adherence, and reduce stigma. Current LAIs are not removable and elicit a long pharmacokinetic (PK) tail. In previous studies, investigational LAI Dolutegravir (DTG) formulations failed to sustain plasma DTG concentrations above the 4× PA-IC90 beyond two months. To overcome these limitations, we propose to…

BIC/FTC/TAF as HIV PEP Was Well-Tolerated With High Adherence and No Seroconversions

Background: Integrase inhibitor-based regimens are the standard of care for HIV post-exposure prophylaxis (PEP), but no such single tablet regimens are recommended in current guidelines. We analyzed tolerability, adherence and HIV seroconversions with bictegravir, emtricitabine and tenofovir alafenamide (B/F/TAF) as HIV PEP in an ongoing clinical trial of text-messaging support versus standard of care for…